文献速递乳腺癌妇科肿瘤

女性癌症生存者减重随机干预试验

Weight Loss Randomized Intervention Trials in Female Cancer Survivors.
PubMed 文献 · J Clin Oncol · 2016-11-07

本文系统综述了针对女性癌症生存者的减重随机对照试验,更新检索2013至2016年文献并查询在研试验。新发现6项乳腺癌和2项子宫内膜癌生存者随机试验,结合既往10项试验,支持招募临近诊断女性的可行性及电话干预减重有效性,并识别出非裔美国生存者显著减重及任何组维持减重的挑战。7项在研试验将评估减重对癌症终点的影响。

要点

  • 电话干预有助于女性癌症生存者实现减重。
  • 非裔美国癌症生存者实现显著减重及任何组维持减重均具挑战。
  • 7项在研随机试验将评估减重对癌症终点的影响。

核心结论

  • 经过十年初步研究,在研随机对照临床试验将可能对减重能否改善乳腺癌临床结局提供确定性评估。
  • 可能需要持续时间超过2年的干预来优化减重维持及对癌症终点的任何潜在获益。

研究设计与样本

  • 对评估减重干预的随机对照临床试验进行系统综述更新(针对2013至2016年发表的文献),并检索临床试验注册库以寻找在研试验。
  • 综述了乳腺癌、子宫内膜癌和卵巢癌生存者中的减重随机试验。

主要发现

  • 新识别出6项乳腺癌生存者随机试验和2项子宫内膜癌生存者随机试验。
  • 这些试验及既往10项女性癌症生存者随机试验的证据支持招募更接近癌症诊断女性的可行性及实现减重的有效性,尤其是电话干预。
  • 识别出非裔美国癌症生存者实现显著减重以及任何癌症生存者组维持减重的挑战。
  • 7项在研随机试验正在评估减重干预对癌症终点的影响(5项乳腺癌、1项卵巢癌、1项子宫内膜癌)。

局限性

  • 具有癌症终点的完整规模确定性减重辅助干预试验仍有待开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Observational study evidence has associated overweight/obesity with decreased survival in women with breast cancer and with several other cancers. Although full-scale, definitive weight loss adjuvant intervention trials with cancer end points remain to be conducted, a number of randomized controlled trials have evaluated weight loss interventions in survivors of cancer in women. Findings from these trials in breast, endometrial, and ovarian cancer are reviewed. Methods A systematic review of randomized controlled clinical trials evaluating weight loss interventions was updated (for studies published 2013 to 2016), and clinical trials registers were searched for ongoing trials. Results Six new randomized trials in breast cancer survivors and two randomized trials in endometrial cancer survivors were identified. Evidence from these trials and the 10 earlier randomized trials in female cancer survivors provide support for the feasibility of recruiting women closer to the cancer diagnosis and efficacy for achieving weight loss, in particular with telephone-based interventions, and have identified the challenge of achieving significant weight loss in African American cancer survivors and of maintaining weight loss in any cancer survivor group. Seven ongoing randomized trials are evaluating the influence of weight loss interventions on cancer end points (five in breast cancer, one in ovarian cancer, and one in endometrial cancer). Conclusion After a decade of preliminary studies, ongoing randomized, controlled clinical trials will potentially provide definitive assessment of whether weight loss can improve breast cancer clinical outcome. Longer-term interventions (> 2 years' duration) may be needed to optimize weight loss maintenance and any potential benefits on cancer end points.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Chlebowski RT, Reeves MM. Weight Loss Randomized Intervention Trials in Female Cancer Survivors. J Clin Oncol. 2016. PMID: 27903147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。